Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Pycnogenol on ADHD: randomized, double-blind, placebo and active product controlled multicenter trial
2016-000215-32Phase 3Terminated
- Sponsor
- University of Antwerp
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of grape seed extract in attention deficit hyperactivity disorder (ADHD) (3 arms), sponsored by University of Antwerp. Primary endpoint: Summed ADHD score of the ADHD-Rating Scale (ADHD-RS) as rated by parents. Started Apr 2016; status: terminated.
02
Drugs
grape seed extract
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2016-000215-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000215-32.